The Efficacy and Safety of Treating Acquired MET Resistance Through Combinations of Parent and MET Tyrosine Kinase Inhibitors in Patients With Metastatic Oncogene-Driven NSCLC
Patil, Tejas, Staley, Alyse, Nie, Yunan, Sakamoto, Mandy, Stalker, Margaret, Jurica, James M., Koehler, Kenna, Cass, Amanda, Kuykendall, Halle, Schmitt, Emily, Filar, Emma, Reventaite, Evelina, Davies, Kurt D., Nijmeh, Hala, Haag, Mary, Yoder, Benjamin A., Bunn, Paul A., Schenk, Erin L., Aisner, Dara L., Iams, Wade T., Marmarelis, Melina E., Camidge, D. Ross
Published in JTO clinical and research reports (01.02.2024)
Published in JTO clinical and research reports (01.02.2024)
Get full text
Journal Article